About: The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1989 (uk) article scientifique publié en 1989 (fr) im Jahr 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1989 (ast) artikull shkencor i botuar më 01 janar 1989 (sq) scientific article published on 01 January 1989 (en)
publication date	wds:Q69739140-82552BC4-24A2-46AC-90FE-5231EF088E15
publication date	1989-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q69739140-01C980D1-87F9-4C66-8273-85A4AFC1E949 wds:Q69739140-1BC11E55-5E91-4B7A-8320-7F8B661D2297 wds:Q69739140-284A19E5-B78A-4F2F-9E39-1E867E813DF9 wds:Q69739140-376C81D8-149A-410B-A6EE-C79207DB57FD wds:Q69739140-3ACC4178-D6A9-4B6B-BBFE-40C269EEE582 wds:Q69739140-4EB0DF11-4696-4DCC-B70F-2B64F6E7DFBF wds:Q69739140-646C6796-1BFE-4022-80B2-0F297369EC8B wds:Q69739140-679B089F-FBC3-4D62-945D-84B27DCB8625 wds:Q69739140-75A95D95-060D-460F-ABC9-9760FDC0EFBA wds:Q69739140-8BEFC7E0-C816-4170-AEDA-F12C1CF2FA5E wds:Q69739140-94C1766B-5C42-4E55-8266-2B48BAA32363 wds:Q69739140-A0237149-76E3-4933-A089-F1E7F1A48856 wds:Q69739140-A288B2FE-0526-4A5F-B39C-28CD2EE55731 wds:Q69739140-BFDBF1FB-0320-4ABA-86B0-0B3B18FF2E9C wds:Q69739140-E4A744F5-25C8-42B0-B912-D1F852F3C365 wds:Q69739140-EC7CD063-9AA4-4538-B643-90E95C1E537A wds:Q69739140-F5266D06-F488-459F-B7F0-7643DB7B21C0
cites work	Colorectal carcinoma antigens detected by hybridoma antibodies Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies Biochemical and epitope analysis of the 17-1A membrane antigen Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody A clinical trial of anti-idiotype therapy for B cell malignancy Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Identification and characterization of the CO17-1A carcinoma-associated antigen Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells Mechanisms of tumor growth inhibition Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies. Anti-idiotypic antibodies to monoclonal antibody CO17-1A Wistar Symposium on Immunodiagnosis and Immunotherapy with CO17-1A MAb in Gastrointestinal Cancer. April 2-3, 1986, Philadelphia, PA
author name string	wds:Q69739140-54F4DE0C-FE59-45C3-82CC-DD0A9E4D3CEB wds:Q69739140-55A9F914-FC7C-413B-BB2A-CEBD078CE7E4 wds:Q69739140-5FC665D5-C0BD-4D0B-84C4-6F646122DC45 wds:Q69739140-73068B6C-EB0C-4A83-8D9E-F2FB367BADFD wds:Q69739140-8DEE0FBF-47A3-4C3D-9358-D2B1AD999C2C wds:Q69739140-9ABA833D-0F5F-4669-ACF5-A0ACC0A4D5C6 wds:Q69739140-BA42A178-62B6-4C47-9802-66F1D8304E9C wds:Q69739140-BD94D40C-9285-46E7-BBB5-4042DC4593E2 wds:Q69739140-C06F10B5-1FA1-42BE-900E-8DE594EFF409 wds:Q69739140-EDF70334-CB99-43E7-B330-0A7BA92F5A40
author name string	P Biberfeld B Christensson H Mellstedt P Ragnhammar J E Frödin J Shetye B Cedermark G Masucci P Pihlstedt J Makower
rdfs:label	The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (en) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (nl) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (sq)
skos:prefLabel	The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (en) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (nl) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (sq)
name	The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (en) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (nl) The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (sq)
title	wds:Q69739140-9508AB43-216D-4BAA-87B0-613D25BD8210
title	The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma (en)
page(s)	wds:Q69739140-C2BF8363-C28E-4D3F-AD2B-32EFFF19DAF5
page(s)	99-107
instance of	wds:Q69739140-EE9430F3-C086-421F-B7A0-5AC8DC4242FA
instance of	scholarly article
main subject	wds:Q69739140-00344A7B-2208-4A48-9CE9-999661B215DE wds:Q69739140-D0A5CCEF-E17C-452A-8AB1-F9DDBB1B0AE5
main subject	monoclonal antibody metastatic colorectal carcinoma
PubMed ID	wds:Q69739140-ADE1FB91-62D3-4449-8F37-C374F432DC3D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2786122
PubMed ID	2786122
published in	wds:Q69739140-81A080E8-FA8B-41FD-85D0-3B147DC9ECD4
published in	Medical oncology and tumor pharmacotherapy
issue	wds:Q69739140-F07A59FB-70E2-4CB7-9273-6DABB580AF84
volume	wds:Q69739140-9CCEBACB-5520-4BD6-8F24-D60CD0909868
issue	1
volume	6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69739140
is cites work of	Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity Chemotherapy and immunotherapy of colorectal cancer Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A). Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor
is cites work of	wds:Q69520036-D025598D-1E95-49D3-B544-2717410CC4B8 wds:Q37010595-0C98490E-EB2C-4031-84FF-F324C1F4520A wds:Q41752014-B40F33EC-C55E-4C80-9F64-4BF4922068F6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software